BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28930812)

  • 1. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma.
    Gunther JR; Christensen EN; Allen PK; Ramondetta LM; Jhingran A; Fleming ND; Euscher ED; Lu KH; Eifel PJ; Klopp AH
    Int J Gynecol Cancer; 2018 Jan; 28(1):114-121. PubMed ID: 28930812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiotherapy for uterine carcinosarcoma: A retrospective assessment of treatment outcomes.
    Yilmaz U; Alanyali S; Aras AB; Ozsaran Z
    J Cancer Res Ther; 2019; 15(6):1377-1382. PubMed ID: 31898676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal brachytherapy for early-stage carcinosarcoma of the uterus.
    Brown LC; Petersen IA; Haddock MG; Bakkum-Gamez JN; Lee LJ; Cimbak NC; Berkowitz RS; Viswanathan AN
    Brachytherapy; 2015; 14(4):433-9. PubMed ID: 25890795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival with combination chemotherapy and external beam radiation therapy in uterine carcinosarcoma.
    McEachron J; Chen YJ; Zhou N; Kao J; Gorelick C; Kanis MJ; Lee YC
    Int J Gynecol Cancer; 2022 Nov; 32(11):1402-1409. PubMed ID: 36343971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma.
    Cantrell LA; Havrilesky L; Moore DT; O'Malley D; Liotta M; Secord AA; Nagel CI; Cohn DE; Fader AN; Wallace AH; Rose P; Gehrig PA
    Gynecol Oncol; 2012 Oct; 127(1):22-6. PubMed ID: 22727985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma.
    McEachron J; Heyman T; Shanahan L; Tran V; Friedman M; Gorelick C; Economos K; Singhal PK; Lee YC; Kanis MJ
    Int J Gynecol Cancer; 2020 Jul; 30(7):1012-1017. PubMed ID: 32447295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08).
    Cha J; Kim YS; Park W; Kim HJ; Kim JY; Kim JH; Kim J; Yoon WS; Kim JW; Kim YB
    J Gynecol Oncol; 2016 Nov; 27(6):e58. PubMed ID: 27550404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
    Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
    Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Adjuvant Pelvic Radiotherapy on Distant Metastasis for Uterine Carcinosarcoma.
    Eng NL; Rana SR; Hall KL; Eng TY
    Am J Clin Oncol; 2021 Apr; 44(4):169-173. PubMed ID: 33481373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcoma.
    Patel N; Hegarty SE; Cantrell LA; Mishra MV; Showalter TN
    Brachytherapy; 2015; 14(5):606-12. PubMed ID: 26166579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
    Klopp AH; Jhingran A; Ramondetta L; Lu K; Gershenson DM; Eifel PJ
    Gynecol Oncol; 2009 Oct; 115(1):6-11. PubMed ID: 19632709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma.
    Einstein MH; Klobocista M; Hou JY; Lee S; Mutyala S; Mehta K; Reimers LL; Kuo DY; Huang GS; Goldberg GL
    Gynecol Oncol; 2012 Jan; 124(1):26-30. PubMed ID: 22055846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of uterine carcinosarcoma: results of 94 patients.
    Gokce ZK; Turan T; Karalok A; Tasci T; Ureyen I; Ozkaya E; Kose MF; Tulunay G
    Int J Gynecol Cancer; 2015 Feb; 25(2):279-87. PubMed ID: 25611900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
    Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: A National Cancer Database analysis.
    Stokes WA; Jones BL; Schefter TE; Fisher CM
    Brachytherapy; 2018; 17(1):194-200. PubMed ID: 29097136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.
    Makker V; Abu-Rustum NR; Alektiar KM; Aghajanian CA; Zhou Q; Iasonos A; Hensley ML
    Gynecol Oncol; 2008 Nov; 111(2):249-54. PubMed ID: 18755503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.
    Rauh-Hain JA; Starbuck KD; Meyer LA; Clemmer J; Schorge JO; Lu KH; Del Carmen MG
    Gynecol Oncol; 2015 Oct; 139(1):84-9. PubMed ID: 26307402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
    Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
    Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.